Logo

Ortho Clinical Diagnostics

JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More

Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.

QuidelOrtho Preliminary Q4 Earnings Beat Estimates

The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent.

QuidelOrtho Continues to See Supply Chain Impacts; Combined Q3 Revenues up 54 Percent
Premium

The firm also said it will shift its near-term regulatory and commercial strategy for its Savanna molecular diagnostic instrument.

QuidelOrtho Reports Preliminary Q3 Revenues

The firm forecast preliminary revenues in the range of $782 million to $785 million for the first full quarter since the merger of Quidel and Ortho Clinical Diagnostics.

QuidelOrtho Board Authorizes $300M Share Repurchase

The firm said it will repurchase up to $300 million in shares of common stock while also prioritizing R&D and manufacturing expansion.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.